Antibodies.com is a biotechnology startup that offers a range of high-quality antibodies, proteins, and ELISA kits at cost-effective prices. Founded in 2015 and headquartered in Cambridge, UK, with additional offices in Stockholm and St. Louis, MO, USA, the company is committed to supporting life science researchers worldwide by providing top-notch products at more affordable prices. The last investment came in the form of a Seed Round at 26 February 2019 from Nidobirds Ventures, signifying investor confidence in the company's potential. Antibodies.com aims to cater to researchers' needs by offering a diverse product range, including primary antibodies, secondary antibodies, ELISA kits, cell-based assays, proteins, peptides, and companion products. The company's dedication to quality is evident through its detailed product datasheets, characterized research tools, and expert customer service. With a focus on delivering discovery at reduced costs, Antibodies.com has positioned itself as a valuable partner for life science researchers. Overall, Antibodies.com's strategic positioning in the biotechnology industry, coupled with its recent Seed Round investment from Nidobirds Ventures, underscores its potential for growth and impact within the life sciences sector.
No recent news or press coverage available for Antibodies.com.